Cost-Containment

The new numbers will affect what some employers owe if employees apply, and get, federal premium subsidies.

The firm sees the astonishingly high cost of "cellular, gene and RNA therapies" — high-tech treatments for conditions like sickle cell disease — as an emerging threat

Dealmaking increased employer plans' childbirth-related hospital bills 3.3% and physician services bills 15%.

A new ethics office filing also shows that Daniel Aronowitz has invested in Cigna, CVS and UnitedHealth.

The risk management giant has no reason to smile when medical inflation pushes insurance premiums higher.

A National Council of Insurance Legislators proposal calls for plans to get dentists' permission before letting outside organizations send them patients.